Michael Ferguson
Corporate Officer/Principal bei ABIVAX
Profil
Michael Ferguson is currently the Chief Commercial Officer at Abivax SA. He holds an MBA from The Pennsylvania State University and an undergraduate degree from St. Joseph's University.
Aktive Positionen von Michael Ferguson
| Unternehmen | Position | Beginn |
|---|---|---|
| ABIVAX | Corporate Officer/Principal | 18.04.2023 |
Ehemalige bekannte Positionen von Michael Ferguson
| Unternehmen | Position | Ende |
|---|---|---|
| ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01.05.2022 |
Ausbildung von Michael Ferguson
| The Pennsylvania State University | Masters Business Admin |
| St. Joseph's University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| ABIVAX | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Arena Pharmaceuticals, Inc.
 Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
